# HEPHAISTOS-Pharma

> Developing anti-tumor immunotherapies

Business model and tags: Pharma & life sciences

## About HEPHAISTOS-Pharma

HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies to revolutionize cancer treatments by enhancing monoclonal antibody effectiveness against incurable tumors

## Key facts

- **Industry**: Biotechnology
- **Company size**: 11–50 employees
- **Headquarters**: Orsay, Île-de-France, France
- **Founded**: 2018
- **Revenue**: €4.5M – €35.3M (Tamtam estimate)
- **Website**: [hephaistos-pharma.fr](https://hephaistos-pharma.fr/)
- **LinkedIn**: [linkedin.com/company/hephaistos-pharma](https://www.linkedin.com/company/hephaistos-pharma)

## HEPHAISTOS-Pharma at a glance

HEPHAISTOS-Pharma is a company in the Biotechnology industry, headquartered in Orsay, Île-de-France, France.

HEPHAISTOS-Pharma was founded in 2018.

HEPHAISTOS-Pharma has 11–50 employees.

HEPHAISTOS-Pharma's revenue is €4.5M – €35.3M (Tamtam estimate).

## Frequently asked questions about HEPHAISTOS-Pharma

### What is HEPHAISTOS-Pharma's revenue?

Tamtam estimates HEPHAISTOS-Pharma's annual revenue at €4.5M – €35.3M.

### How many employees does HEPHAISTOS-Pharma have?

HEPHAISTOS-Pharma has 11–50 employees.

### Where is HEPHAISTOS-Pharma headquartered?

HEPHAISTOS-Pharma is headquartered in Orsay, Île-de-France, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/hephaistos-pharma